Search research articles
Contact Us
Filters
Showing results (341-350 of 387) with videos related to
Page
of 39
Sort By:
The Lancet. Gastroenterology & Hepatology
|
December 15, 2025
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
Jeffrey V Lazarus, Leire Agirre-Garrido, Trenton M White, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2022
APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients
Nipun Verma, Ashok Choudhury, Virendra Singh, et al.
Hepatology (Baltimore, Md.)
|
August 17, 2018
Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy
Lovkesh Anand, Ashok Choudhury, Chhagan Bihari, et al.
Journal of Clinical and Experimental Hepatology
|
March 8, 2021
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver
Pankaj Puri, Radha K Dhiman, Sunil Taneja, et al.
Journal of Clinical and Experimental Hepatology
|
March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India
Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology
|
February 7, 2020
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations
Ashish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
The American Journal of Gastroenterology
|
March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease
Naim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.
Alimentary Pharmacology & Therapeutics
|
May 13, 2026
Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP-INDIA Study
Nipun Verma, Rohit Mehtani, Arun Valsan, et al.
Journal of Clinical and Experimental Hepatology
|
March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India
Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology
|
February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study
Narendra S Choudhary, Ajay Duseja, Arka De, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 387) with videos related to
Sort By:
Page
of 39
The Lancet. Gastroenterology & Hepatology
|
December 15, 2025
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
Jeffrey V Lazarus, Leire Agirre-Garrido, Trenton M White, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2022
APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients
Nipun Verma, Ashok Choudhury, Virendra Singh, et al.
Hepatology (Baltimore, Md.)
|
August 17, 2018
Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy
Lovkesh Anand, Ashok Choudhury, Chhagan Bihari, et al.
Journal of Clinical and Experimental Hepatology
|
March 8, 2021
Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver
Pankaj Puri, Radha K Dhiman, Sunil Taneja, et al.
Journal of Clinical and Experimental Hepatology
|
March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India
Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology
|
February 7, 2020
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations
Ashish Kumar, Subrat K Acharya, Shivaram P Singh, et al.
The American Journal of Gastroenterology
|
March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver Disease
Naim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.
Alimentary Pharmacology & Therapeutics
|
May 13, 2026
Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP-INDIA Study
Nipun Verma, Rohit Mehtani, Arun Valsan, et al.
Journal of Clinical and Experimental Hepatology
|
March 11, 2015
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India
Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology
|
February 12, 2026
Type 2 Diabetes Mellitus and Risk of Advanced Fibrosis in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): The Results of Multi-centre Indian Consortium on MASLD (ICOM-D) Study
Narendra S Choudhary, Ajay Duseja, Arka De, et al.
Page
of 39